Krishna Institute of Medical Sciences Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹1,075Cr
- +34.9% YoY
- +7.7% QoQ
- Net profit
- ₹33Cr
- −68.9% YoY
- −36.5% QoQ
- Margin
- 19%
- −6 pp YoY
- −1 pp QoQ
Guidance rank: #11 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Krishna Institute of Medical Sciences Ltd Q4 FY26 key numbers
- Revenue
- Bangalore hospitals' occupancy expected to reach 35-40% by end of next financial year, with ARPOB stabilizing around INR 75,000 initially and improving over time.
As stated in Krishna Institute of Medical Sciences Ltd's Q4 FY26 earnings call transcript · published 24 May 2026. Reported figures, not investment advice.
The short version
KIMS Hospitals expects steady expansion over the next 3 to 5 years with both Greenfield and Brownfield projects in Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, and Telangana. The company expects a steady expansion over the next 3 to 5 years, aiming to maintain similar growth levels as in the past five years.
From Krishna Institute of Medical Sciences Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- KIMS Hospitals expects steady expansion over the next 3 to 5 years with both Greenfield and Brownfield projects in Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, and Telangana.
- New hospitals in Bangalore (Mahadevapuram, Electronic City) and Telangana (Kondapur, Kompally) are expected to ramp up and become EBITDA positive, contributing to volume-driven growth in the next 4-5 years.
- IP and OP volumes grew by 15.4% and 25.4% respectively in FY '26, with sustained upward trends anticipated.
- Bangalore hospitals' occupancy expected to reach 35-40% by end of next financial year, with ARPOB stabilizing around INR 75,000 initially and improving over time.
- Telangana cluster anticipates healthy EBITDA growth of around 10%-12% in FY '27.
2 more points from Krishna Institute of Medical Sciences Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Krishna Institute of Medical Sciences Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company plans steady expansion, including both Greenfield and Brownfield projects, over the next 3-5 years.
- Next 12-24 months focus on consolidating current hospitals and expanding margins.
- Greenfield projects planned in Karnataka, Kerala, Tamil Nadu (1 new hospital), Andhra Pradesh, and Telangana.
- Expansion involves adding more beds year-on-year; beds at Kondapur new facility to be commissioned in phases (400-500 beds in Phase 1, remaining 300 phased based on occupancy).
- Remaining CAPEX of around INR 50-75 crores for Kondapur to be incurred in FY '28 and beyond.
- Acquisitions of smaller hospitals (approx. 400-500 beds collectively) possible within next two quarters.
2 more points from Krishna Institute of Medical Sciences Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Krishna Institute of Medical Sciences Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Krishna Institute of Medical Sciences Ltd's call on order book
Create a free account to keep reading this call
Krishna Institute of Medical Sciences Ltd — Quarterly revenue & net profit
Krishna Institute of Medical Sciences Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 1,075 | 797 | +34.9% | 998 | +7.7% |
| Operating profit (EBITDA) | 206 | 198 | +4% | 199 | +3.5% |
| Operating margin | 19% | 25% | -6 pp | 20% | -1 pp |
| Profit before tax | 55 | 134 | -59% | 69 | -20.3% |
| Net profit (PAT) | 33 | 106 | -68.9% | 52 | -36.5% |
| EPS (₹) | 1.06 | 2.54 | -58.3% | 1.33 | -20.3% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.3K Cr, net profit ₹75 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Krishna Institute of Medical Sciences's management said in earlier quarters
Others in Healthcare Services this season
- Suven Life Sciences (Q4 FY26)
The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su
- Invicta Diagnostic (Q4 FY26)
Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…
- KMC Speciality (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Krishna Institute of Medical Sciences Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Krishna Institute of Medical Sciences Ltd Q4 FY26 results?
KIMS Hospitals expects steady expansion over the next 3 to 5 years with both Greenfield and Brownfield projects in Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, and Telangana. The company expects a steady expansion over the next 3 to 5 years, aiming to maintain similar growth levels as in the past five years.
What is Krishna Institute of Medical Sciences Ltd share price analysis?
Krishna Institute of Medical Sciences Ltd currently shows a neutral. The stock trades at a P/E of 161.5 with a market cap of ₹33,691 Cr. Investors should review the full earnings analysis for detailed insights.
Is Krishna Institute of Medical Sciences Ltd planning capital expenditure?
The company plans steady expansion, including both Greenfield and Brownfield projects, over the next 3-5 years. - Next 12-24 months focus on consolidating current hospitals and expanding margins. - Greenfield projects planned in Karnataka, Kerala, Tamil Nadu (1 new hospital), Andhra Pradesh, and Telangana. - Expansion involves adding more beds year-on-year; beds at Kondapur new facility to be commissioned in phases (400-500 beds in Phase 1, remaining 300 phased based on occupancy). - Remaining CAPEX of around INR 50-75 crores for Kondapur to be incurred in FY '28 and beyond. - Acquisitions of smaller hospitals (approx.
Keep Krishna Institute of Medical Sciences Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
